Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)
China · Delayed Price · Currency is CNY 65.08
-3.68 (-5.35%)
May 12, 2026, 3:00 PM CST
SHA:688399 Market Cap
SHA:688399 has a market cap or net worth of 5.46 billion as of May 12, 2026. Its market cap has increased by 51.62% in one year.
Market Cap
5.46B
Enterprise Value
4.29B
Revenue
326.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
65.08
Market Cap Chart
Since December 5, 2019, SHA:688399's market cap has increased from 3.22B to 5.46B, an increase of 69.67%. That is a compound annual growth rate of 8.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 5.77B | 0.38% |
| Dec 31, 2025 | 5.75B | 54.17% |
| Dec 31, 2024 | 3.73B | 16.52% |
| Dec 29, 2023 | 3.20B | -37.80% |
| Dec 30, 2022 | 5.14B | -36.21% |
| Dec 31, 2021 | 8.06B | -28.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaResources (Shanghai) | 6.11B |
| R&G PharmaStudies | 5.98B |
| Shenzhen Weiguang Biological Products | 5.92B |
| Beijing Konruns Pharmaceutical | 5.80B |
| Lifecome Biochemistry | 5.73B |
| Kexing Biopharm | 5.25B |
| Wuhan Hvsen Biotechnology | 5.24B |
| ChemPartner PharmaTech | 5.05B |